{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:21:31Z","timestamp":1794640891463,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sex-based differences in atrial fibrillation (AF) symptom burden and response to rhythm control strategies are recognised. Whether female and male patients differ in escalation to atrioventricular (AV) node ablation after AF catheter ablation remains uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate sex differences in AV node ablation following AF ablation in a large real-world cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults undergoing first-time AF ablation between 2015 and 2024 were identified from a global federated research network. Patients with prior AV node ablation or cardiac implantable electronic devices were excluded. Female and male patients were compared before and after 1:1 propensity score matching for demographics, AF type, heart failure phenotype, co-morbidities, medication use and prior cardioversion. The primary outcome was AV node ablation within 5 years. Secondary outcomes included repeat AF ablation, electrical cardioversion and all-cause mortality. Pre-specified falsification endpoints (pneumonia and intestinal obstruction) were assessed to evaluate residual confounding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Before matching (28,004 female; 52,137 male), AV node ablation occurred in 2.5% of female and 1.1% of male patients (risk ratio [RR] 2.31, 95% CI 2.07\u20132.58). After matching (24,377 female and 24,377 male), baseline characteristics were well balanced, yet AV node ablation remained more frequent in female than male patients (2.3% vs. 1.2%; RR 1.94, 95% CI 1.68\u20132.23). Female patients were also more likely to undergo repeat AF ablation (14.7% vs. 14.1%; RR 1.04, 95% CI 1.01\u20131.08), whilst mortality was modestly lower (4.5% vs. 4.9%; RR 0.91, 95% CI 0.84\u20130.99;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.027). Falsification endpoints did not differ between groups after matching.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Female patients were more likely than male patients to undergo AV node ablation following AF ablation despite robust adjustment, suggesting important sex-based differences in downstream AF management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s10840-026-02395-7","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:25:12Z","timestamp":1782915912000},"page":"2821-2830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex differences in escalation to atrioventricular node ablation following catheter ablation for atrial fibrillation"],"prefix":"10.1007","volume":"69","author":[{"given":"Rosie","family":"Oatham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-7739","authenticated-orcid":false,"given":"Mark T.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2395_CR1","doi-asserted-by":"publisher","unstructured":"Mills MT, Lip GYH, Luther V, Gupta D. Sex - based differences in symptomatology in the first month following atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol. 2025;36(9):2271\u20138. https:\/\/doi.org\/10.1111\/jce.70009.","DOI":"10.1111\/jce.70009"},{"key":"2395_CR2","doi-asserted-by":"publisher","unstructured":"Lip GYH, Laroche C, Boriani G, et al. Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation. Europace. 2015;17(1):24\u201331. https:\/\/doi.org\/10.1093\/europace\/euu155.","DOI":"10.1093\/europace\/euu155"},{"key":"2395_CR3","doi-asserted-by":"publisher","unstructured":"Kloosterman M, Crijns HJGM, Mulder BA, et al. Sex-related differences in risk factors, outcome, and quality of life in patients with permanent atrial fibrillation: results from the RACE II study. Europace. 2020;22(11):1619\u201327. https:\/\/doi.org\/10.1093\/europace\/euz300.","DOI":"10.1093\/europace\/euz300"},{"key":"2395_CR4","doi-asserted-by":"publisher","unstructured":"Linde C, Bongiorni MG, Birgersdotter-Green U, et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. EP Europace. 2018;20:1565\u2013ao1565. https:\/\/doi.org\/10.1093\/europace\/euy067.","DOI":"10.1093\/europace\/euy067"},{"key":"2395_CR5","doi-asserted-by":"publisher","unstructured":"Corica B, Lobban T, Hills MT, et al. Sex as a risk factor for Atrial Fibrillation-Related Stroke. Thromb Haemost. 2024;124:281\u20135. https:\/\/doi.org\/10.1055\/s-0043-1776394.","DOI":"10.1055\/s-0043-1776394"},{"key":"2395_CR6","doi-asserted-by":"publisher","unstructured":"Dagres N, Nieuwlaat R, Vardas PE, et al. Gender-related differences in presentation, treatment, and outcome of patients with Atrial Fibrillation in Europe a report from the Euro Heart Survey on Atrial Fibrillation. J Am Coll Cardiol. 2007;49(5):572\u20137. https:\/\/doi.org\/10.1016\/j.jacc.2006.10.047.","DOI":"10.1016\/j.jacc.2006.10.047"},{"key":"2395_CR7","doi-asserted-by":"publisher","unstructured":"Mills MT, Bucci T, Calvert P, Gupta D, Lip GYH. Temporal trends in the association between female sex and ischemic stroke among patients with atrial fibrillation. J Am Heart Assoc. 2025;14(13):1\u20139. https:\/\/doi.org\/10.1161\/JAHA.124.040325.","DOI":"10.1161\/JAHA.124.040325"},{"key":"2395_CR8","doi-asserted-by":"publisher","unstructured":"Piccini JP, Simon DN, Steinberg BA, et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men: two-year results from the ORBIT-AF Registry. JAMA Cardiol. 2016;1(3):282\u20139. https:\/\/doi.org\/10.1001\/jamacardio.2016.0529.","DOI":"10.1001\/jamacardio.2016.0529"},{"issue":"Jun","key":"2395_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/JAHA.116.005401","volume":"6","author":"S Blum","year":"2017","unstructured":"Blum S, Muff C, Aeschbacher S, et al. Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation. J Am Heart Assoc. 2017;6(Jun):1\u20137. https:\/\/doi.org\/10.1161\/JAHA.116.005401.","journal-title":"J Am Heart Assoc"},{"key":"2395_CR10","doi-asserted-by":"publisher","unstructured":"Gleason KT, Himmelfarb CRD, Ford DE, et al. Association of sex and atrial fibrillation therapies with patient-reported outcomes. Heart. 2020;105(21):1642\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2019-314881.","DOI":"10.1136\/heartjnl-2019-314881"},{"key":"2395_CR11","doi-asserted-by":"publisher","unstructured":"Weberndorfer V, Beinart R, Ricciardi D, et al. Sex differences in rate and rhythm control for atrial fibrillation. Europace. 2019;21(5):690\u20137. https:\/\/doi.org\/10.1093\/europace\/euy295.","DOI":"10.1093\/europace\/euy295"},{"issue":"Oct","key":"2395_CR12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jacc.2005.05.078","volume":"46","author":"M Rienstra","year":"2005","unstructured":"Rienstra M, Van Veldhuisen DJ, Hagens VE, et al. Gender-Related Differences in Rhythm Control Treatment in Persistent Atrial Fibrillation: Data of the Rate Control Versus Electrical Cardioversion (RACE) Study. J Am Coll Cardiol. 2005;46(Oct):1298\u2013306. https:\/\/doi.org\/10.1016\/j.jacc.2005.05.078.","journal-title":"J Am Coll Cardiol"},{"key":"2395_CR13","doi-asserted-by":"publisher","unstructured":"Silva RL, Guhl EN, Althouse AD, Herbert B, Sharbaugh M, Essien UR, et al. Sex differences in atrial fibrillation: patient-reported outcomes and the persistent toll on women. Am J Prev Cardiol. 2021;8:100252. https:\/\/doi.org\/10.1016\/j.ajpc.2021.100252.","DOI":"10.1016\/j.ajpc.2021.100252"},{"key":"2395_CR14","doi-asserted-by":"publisher","unstructured":"Forleo GB, Tondo C, De Luca L, et al. Gender-related differences in catheter ablation of atrial fibrillation. Europace. 2007;9(8):613\u201320. https:\/\/doi.org\/10.1093\/europace\/eum144.","DOI":"10.1093\/europace\/eum144"},{"key":"2395_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.hrthm.2009.10.025","volume":"7","author":"D Patel","year":"2010","unstructured":"Patel D, Mohanty P, Di Biase L, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7:167\u201372. https:\/\/doi.org\/10.1016\/j.hrthm.2009.10.025.","journal-title":"Heart Rhythm"},{"key":"2395_CR16","doi-asserted-by":"publisher","unstructured":"Roten L, Rimoldi SF, Schwick N, et al. Gender differences in patients referred for atrial fibrillation management to a tertiary center. Pacing Clin Electrophysiol. 2009;32:622\u20136. https:\/\/doi.org\/10.1111\/j.1540-8159.2009.02335.x.","DOI":"10.1111\/j.1540-8159.2009.02335.x"},{"key":"2395_CR17","doi-asserted-by":"publisher","unstructured":"Coughtrie AL, Behr ER, Layton D et al. Drugs and life-threatening ventricular arrhythmia risk: results from the DARE study cohort. BMJ Open 2017;7(10):1\u201310. https:\/\/doi.org\/10.1136\/bmjopen-2017-016627.","DOI":"10.1136\/bmjopen-2017-016627"},{"issue":"Mar","key":"2395_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/s0002-9149(02)03378-7","volume":"91","author":"DL Wolbrette","year":"2003","unstructured":"Wolbrette DL. Risk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issues. Am J Cardiol. 2003;91(Mar):39\u201344. https:\/\/doi.org\/10.1016\/s0002-9149(02)03378-7.","journal-title":"Am J Cardiol"},{"key":"2395_CR19","doi-asserted-by":"publisher","unstructured":"Schnabel RB, Yin X, Gona P et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet 2015;386(9989):154\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(14)61774-8.","DOI":"10.1016\/S0140-6736(14)61774-8"},{"key":"2395_CR20","doi-asserted-by":"publisher","unstructured":"Airaksinen KE, Gronberg T, Nuotio I, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: the finCV (Finnish CardioVersion) study. J Am Coll Cardiol. 2013;62:1187\u201392. https:\/\/doi.org\/10.1016\/j.jacc.2013.04.089.","DOI":"10.1016\/j.jacc.2013.04.089"},{"key":"2395_CR21","doi-asserted-by":"publisher","unstructured":"Takigawa M, Kuwahara T, Takahashi A, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. Int J Cardiol. 2013;168:1984\u201391. https:\/\/doi.org\/10.1016\/j.ijcard.2012.12.101.","DOI":"10.1016\/j.ijcard.2012.12.101"},{"key":"2395_CR22","doi-asserted-by":"publisher","unstructured":"Hoyt H, Bhonsale A, Chilukuri K, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011;8:1869\u201374. https:\/\/doi.org\/10.1016\/j.hrthm.2011.07.025.","DOI":"10.1016\/j.hrthm.2011.07.025"},{"key":"2395_CR23","doi-asserted-by":"publisher","unstructured":"Padala SK, Gunda S, Sharma PS, et al. Risk model for predicting complications in patients undergoing atrial fibrillation ablation. Heart Rhythm. 2017;14:1336\u201343. https:\/\/doi.org\/10.1016\/j.hrthm.2017.04.042.","DOI":"10.1016\/j.hrthm.2017.04.042"},{"key":"2395_CR24","doi-asserted-by":"publisher","unstructured":"Inoue K, Murakawa Y, Nogami A, et al. Clinical and procedural predictors of early complications of ablation for atrial fibrillation: analysis of the national registry data. Heart Rhythm. 2014;11:2247\u201353. https:\/\/doi.org\/10.1016\/j.hrthm.2014.08.021.","DOI":"10.1016\/j.hrthm.2014.08.021"},{"key":"2395_CR25","doi-asserted-by":"publisher","unstructured":"Hermida A, Burtin J, Kubala M, et al. Sex differences in the outcomes of cryoablation for atrial fibrillation. Front Cardiovasc Med 2022;9,(893553):1\u201310. https:\/\/doi.org\/10.3389\/fcvm.2022.893553.","DOI":"10.3389\/fcvm.2022.893553"},{"key":"2395_CR26","doi-asserted-by":"publisher","unstructured":"Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427\u2013520. https:\/\/doi.org\/10.1093\/eurheartj\/ehab364.","DOI":"10.1093\/eurheartj\/ehab364"},{"key":"2395_CR27","doi-asserted-by":"publisher","unstructured":"Chatterjee NA, Upadhyay GA, Ellenbogen KA, et al. Atrioventricular Nodal Ablation in Atrial Fibrillation: a meta-analysis and systematic review. Circ Arrhythm Electrophysiol. 2011;5:68\u201376. https:\/\/doi.org\/10.1161\/CIRCEP.111.967810.","DOI":"10.1161\/CIRCEP.111.967810"},{"key":"2395_CR28","doi-asserted-by":"publisher","unstructured":"Brignole M, Pentimalli F, Palmisano P et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;42(46):4731\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehab569.","DOI":"10.1093\/eurheartj\/ehab569"},{"key":"2395_CR29","doi-asserted-by":"publisher","unstructured":"Tan ES, Rienstra M, Wiesfeld ACP, et al. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Europace 2008;10(4):412\u20138. https:\/\/doi.org\/10.1093\/europace\/eun020.","DOI":"10.1093\/europace\/eun020"},{"issue":"2Jun","key":"2395_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1023\/A:1009795330454","volume":"2","author":"GN Kay","year":"1998","unstructured":"Kay GN, Ellenbogen KA, Giudici M, et al. The Ablate and Pace Trial: A Prospective Study of Catheter Ablation of the AV Conduction System and Permanent Pacemaker Implantation for Treatment of Atrial Fibrillation. J Interv Card Electrophysiol. 1998;2(2Jun):121\u201335. https:\/\/doi.org\/10.1023\/A:1009795330454.","journal-title":"J Interv Card Electrophysiol"},{"key":"2395_CR31","doi-asserted-by":"publisher","unstructured":"Weerasooriya R, Davis M, Powell A, et al. The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). J Am Coll Cardiol. 2003;41:1697\u2013702. https:\/\/doi.org\/10.1016\/S0735-1097(03)00338-3.","DOI":"10.1016\/S0735-1097(03)00338-3"},{"key":"2395_CR32","doi-asserted-by":"publisher","unstructured":"Wood MA, Brown-Mahoney C, Kay GN, Ellenbogen KA. Clinical outcomes after ablation and pacing therapy for atrial fibrillation: a meta-analysis. Circulation. 2000;101(10):1138\u201344. https:\/\/doi.org\/10.1161\/01.CIR.101.10.1138.","DOI":"10.1161\/01.CIR.101.10.1138"},{"key":"2395_CR33","doi-asserted-by":"publisher","unstructured":"Russo AM, Zeitler EP, Giczewska A et al. Association between sex and treatment outcomes of atrial fibrillation ablation versus drug therapy: results from the CABANA trial. Circulation 2021;143(7):661\u201372. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051558.","DOI":"10.1161\/CIRCULATIONAHA.120.051558"},{"key":"2395_CR34","doi-asserted-by":"publisher","unstructured":"Lim K-T, Davis MJE, Powell A, et al. Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial. Europace 2007;9(7):498\u2013505. https:\/\/doi.org\/10.1093\/europace\/eum091.","DOI":"10.1093\/europace\/eum091"},{"key":"2395_CR35","doi-asserted-by":"publisher","unstructured":"Mills MT, Calvert P, Lip GYH, Luther V, Gupta D. Outcomes of vascular closure devices for femoral venous hemostasis following catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2024;35:1656\u201362. https:\/\/doi.org\/10.1111\/jce.16345.","DOI":"10.1111\/jce.16345"},{"issue":"Oct","key":"2395_CR36","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jacep.2023.06.008","volume":"9","author":"MR Abu-Qaoud","year":"2023","unstructured":"Abu-Qaoud MR, Kmar A, Tarun R, et al. Impact of SGLT2 Inhibitors on AF Recurrence After Catheter Ablation in Patients With Type 2 Diabetes. JACC Clin Electrophysiol. 2023;9(Oct):2109\u201318. https:\/\/doi.org\/10.1016\/j.jacep.2023.06.008.","journal-title":"JACC Clin Electrophysiol"},{"key":"2395_CR37","doi-asserted-by":"publisher","unstructured":"Aglan A, Fath AR, Maron BJ et al. Percutaneous left atrial appendage closure for stroke prevention in hypertrophic cardiomyopathy patients with atrial fibrillation. Heart Rhythm 2024;21(9):1677\u201383. https:\/\/doi.org\/10.1016\/j.hrthm.2024.05.038.","DOI":"10.1016\/j.hrthm.2024.05.038"},{"key":"2395_CR38","doi-asserted-by":"publisher","unstructured":"Palchuk MB, London JW, Perez-Rey D, et al. A global federated real-world data and analytics platform for research. JAMIA Open. 2023;6:ooad035. https:\/\/doi.org\/10.1093\/jamiaopen\/ooad035.","DOI":"10.1093\/jamiaopen\/ooad035"},{"key":"2395_CR39","doi-asserted-by":"publisher","unstructured":"Topaloglu U, Palchuk MB. Using a federated network of real-world data to optimize clinical trials operations. JCO Clin Cancer Inf. 2018;2:1\u201310. https:\/\/doi.org\/10.1200\/CCI.17.00067.","DOI":"10.1200\/CCI.17.00067"},{"key":"2395_CR40","doi-asserted-by":"publisher","unstructured":"Winkle RA, Jarman JWE, Mead RH, et al. Predicting atrial fibrillation ablation outcome: the CAAP-AF score. Heart Rhythm. 2016;13:2119\u201325. https:\/\/doi.org\/10.1016\/j.hrthm.2016.07.018.","DOI":"10.1016\/j.hrthm.2016.07.018"},{"issue":"Mar","key":"2395_CR41","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/joa3.13023","volume":"40","author":"P Calvert","year":"2024","unstructured":"Calvert P, Ding WY, Griffin M, et al. Predictors of the need for atrioventricular nodal ablation following redo ablation for atrial fibrillation. J Arrhythm. 2024;40(Mar):501\u20137. https:\/\/doi.org\/10.1002\/joa3.13023.","journal-title":"J Arrhythm"},{"key":"2395_CR42","doi-asserted-by":"publisher","unstructured":"Lee K-N, Roh S-Y, Baek Y-S, et al. Long-term clinical comparison of procedural end points after pulmonary vein isolation in paroxysmal atrial fibrillation: elimination of nonpulmonary vein triggers verses noninducibility. Circ Arrhythmia Electrophysiol. 2018;11:e005019. https:\/\/doi.org\/10.1161\/CIRCEP.117.005019.","DOI":"10.1161\/CIRCEP.117.005019"},{"key":"2395_CR43","doi-asserted-by":"publisher","unstructured":"Duarte F, Silva-Teixeira R, Aguiar-Neves I, et al. Sex differences in atrial remodeling and atrial fibrillation recurrence after catheter ablation. Heart Rhythm. 2025;22:e563\u201371. https:\/\/doi.org\/10.1016\/j.hrthm.2025.02.003.","DOI":"10.1016\/j.hrthm.2025.02.003"},{"key":"2395_CR44","doi-asserted-by":"publisher","unstructured":"Yamaguchi T, Tsuchiya T, Fukui A, et al. Impact of the extent of low-voltage zone on outcomes after voltage-based catheter ablation for persistent atrial fibrillation. J Cardiol. 2018;72:427\u201333. https:\/\/doi.org\/10.1016\/j.jjcc.2018.04.010.","DOI":"10.1016\/j.jjcc.2018.04.010"},{"key":"2395_CR45","doi-asserted-by":"publisher","unstructured":"Baumgartner T, Kaelin-Friedrich M, Makowski K, et al. Sex-related differences in patient selection for and outcomes after pace and ablate for refractory atrial fibrillation: insights from a large multicenter cohort. J Clin Med. 2022;11(16):4927. https:\/\/doi.org\/10.3390\/jcm11164927.","DOI":"10.3390\/jcm11164927"},{"key":"2395_CR46","doi-asserted-by":"publisher","unstructured":"Pak H-N, Park J-W, Yang S-Y, et al. Sex differences in mapping and rhythm outcomes of a repeat atrial fibrillation ablation. Heart 2021;107(23):1862\u20137. https:\/\/doi.org\/10.1136\/heartjnl-2020-318282.","DOI":"10.1136\/heartjnl-2020-318282"},{"key":"2395_CR47","doi-asserted-by":"publisher","unstructured":"Masuda M, Matsuda Y, Uematsu H, et al. Gender differences in atrial fibrosis and cardiomyopathy assessed by left atrial low-voltage areas during catheter ablation of atrial fibrillation. Am J Cardiol. 2023;203:37\u201344. https:\/\/doi.org\/10.1016\/j.amjcard.2023.07.001.","DOI":"10.1016\/j.amjcard.2023.07.001"},{"key":"2395_CR48","doi-asserted-by":"publisher","unstructured":"Akoum N, Mahnkopf C, Kholmovski EG, et al. Age and sex differences in atrial fibrosis among patients with atrial fibrillation. Europace 2018;20(7):1086\u201392. https:\/\/doi.org\/10.1093\/europace\/eux260.","DOI":"10.1093\/europace\/eux260"},{"key":"2395_CR49","doi-asserted-by":"publisher","unstructured":"Kim T-H, Park J, Uhm J-S, et al. Pulmonary vein reconnection predicts good clinical outcome after second catheter ablation for atrial fibrillation. Europace 2017;19(6):961\u20137. https:\/\/doi.org\/10.1093\/europace\/euw128.","DOI":"10.1093\/europace\/euw128"},{"key":"2395_CR50","doi-asserted-by":"publisher","unstructured":"Gleason KT, Nazarian S, Dennison Himmelfarb CR. Atrial fibrillation symptoms and sex, race, and psychological distress: a literature review. J Cardiovasc Nurs. 2018;33(2):137\u201343. https:\/\/doi.org\/10.1097\/JCN.0000000000000421.","DOI":"10.1097\/JCN.0000000000000421"},{"key":"2395_CR51","doi-asserted-by":"publisher","unstructured":"Gleason KT, Dennison Himmelfarb CR, Ford DE, et al. Association of sex, age and education level with patient reported outcomes in atrial fibrillation. BMC Cardiovasc Disord. 2019;19:1\u201312. https:\/\/doi.org\/10.1186\/s12872-019-1059-6.","DOI":"10.1186\/s12872-019-1059-6"},{"key":"2395_CR52","doi-asserted-by":"publisher","unstructured":"Tan JL, Johnson L, Dziubinski M, et al. Sex differences in presentation of atrial fibrillation: findings from 30-day ambulatory monitoring in real-world practice. Am Hear J Plus. 2022;22:100208. https:\/\/doi.org\/10.1016\/j.ahjo.2022.100208.","DOI":"10.1016\/j.ahjo.2022.100208"},{"key":"2395_CR53","doi-asserted-by":"publisher","unstructured":"Gaur P, Ganguly AP, Kuo M, et al. Childcare needs as a barrier to healthcare among women in a safety-net health system. BMC Public Health. 2024;24:1608. https:\/\/doi.org\/10.1186\/s12889-024-19125-1.","DOI":"10.1186\/s12889-024-19125-1"},{"key":"2395_CR54","doi-asserted-by":"publisher","unstructured":"Elliott MK, de Vere F, Mehta VS, et al. Rate or rhythm control in CRT (RHYTHMIC): study rationale and protocol. Heart Rhythm O2 2022;3(no 6 Part A):681\u20137. https:\/\/doi.org\/10.1016\/j.hroo.2022.09.001.","DOI":"10.1016\/j.hroo.2022.09.001"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02395-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02395-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:50:51Z","timestamp":1794639051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02395-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":54,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02395-7","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"GYHL reports: Consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo, Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) Senior Investigator Emeritus and co-PI of the AFFIRMO project on multimorbidity in AF (grant agreement No 899871), TARGET project on digital twins for personalised management of atrial fibrillation and stroke (grant agreement No 101136244) and ARISTOTELES project on artificial intelligence for management of chronic long term conditions (grant agreement No 101080189), which are all funded by the EU\u2019s Horizon Europe Research & Innovation programme. RO and MTM declare no conflicts of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}